Since amyloid-beta (Aβ) plaques are a hallmark of Alzheimer's disease and these deposits are rich in heparan sulfate proteoglycans, which can bind to bFGF and serum amyloid P components, the researchers explored a new method of ligand delivery to the brain. The gene discussed is FGF2; the disease is early-onset autosomal dominant Alzheimer disease.